COUPLING OF M-CHOLINOCEPTORS AND A(1) ADENOSINE RECEPTORS IN HUMAN MYOCARDIUM

被引:23
作者
BOHM, M [1 ]
GIERSCHIK, P [1 ]
SCHWINGER, RHG [1 ]
UHLMANN, R [1 ]
ERDMANN, E [1 ]
机构
[1] UNIV ULM, INST PHARMAKOL, D-85065 ULM, GERMANY
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1994年 / 266卷 / 05期
关键词
GUANINE NUCLEOTIDE-BINDING PROTEINS; HUMAN HEART; FORCE OF CONTRACTION;
D O I
10.1152/ajpheart.1994.266.5.H1951
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
This study investigated the coupling of M-cholinoceptors and A(1) adenosine receptors in human myocardium. Carbachol reduced force of contraction in atria and ventricles by 60 and 35% (in the presence of 0.03 mu M isoprenaline), respectively. Addition of (-)-N-6-(2-phenylisopropyl)adenosine (R-PIA) in the presence of carbachol did not further reduce force of contraction. R-PIA reduced force of contraction less than carbachol in atria (ventricles) by 35% (25%), but addition of carbachol after R-PIA reduced force of contraction further by 35% (15%). Carbachol increased S-35-labeled guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) binding maximally 14-fold only when GDP was present by an excess of > 100 times [S-35]GTP gamma S, while R-PIA increased binding only 2-fold. Activation of [S-35]GTP gamma S binding by A(1) adenosine receptor and M-cholinoceptor stimulation was antagonized by theophylline and atropine, respectively. Addition of R-PLA. to carbachol did not further increase [S-35]GTP gamma S binding. Activation of high-affinity [S-35]GTP gamma S binding by agonists showed that carbachol activated [S-35]GTP gamma S binding to 20 pmol/mg protein [S-35]GTP gamma S binding sites, i.e., 25% of the total number of binding sites (80 pmol/mg protein). With R-PIA, activation of high-affinity [S-35]GTP gamma S binding could not reliably be detected with this technique. From the number of M-cholinoceptors (atria, 360 fmol/mg protein; ventricle, 270 fmol/mg protein), it is estimated that 1 M-cholinoceptor activates similar to 50-80 G protein ol-subunits in atria and ventricles, respectively. It is concluded that stimulation of M-cholinoceptors but not A(1) adenosine receptors is able to maximally activate a pool of G protein alpha-subunits. A catalytic activation of G protein alpha-subunits by M-cholinoceptors was demonstrated. Because A(1) adenosine receptors mediate 40-50% of the maximal effects produced by M-cholinoceptors but their density is only 8-10% of the M-cholinoceptor density, A(1) adenosine receptors are Likely to be coupled more efficiently than M-cholinoceptors in the human heart.
引用
收藏
页码:H1951 / H1958
页数:8
相关论文
共 37 条
[1]   INHIBITORY-ACTION OF ADENOSINE ON HISTAMINE-STIMULATED AND DOPAMINE-STIMULATED CARDIAC CONTRACTILITY AND ADENYLATE-CYCLASE IN GUINEA-PIGS [J].
BAUMANN, G ;
SCHRADER, J ;
GERLACH, E .
CIRCULATION RESEARCH, 1981, 48 (02) :259-266
[2]   ADENOSINE SYSTEM IN THE HEART [J].
BELARDINELLI, L .
DRUG DEVELOPMENT RESEARCH, 1993, 28 (03) :263-267
[3]   ISOLATED ATRIAL MYOCYTES - ADENOSINE AND ACETYLCHOLINE INCREASE POTASSIUM CONDUCTANCE [J].
BELARDINELLI, L ;
ISENBERG, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 244 (05) :H734-H737
[4]   THE CARDIAC EFFECTS OF ADENOSINE [J].
BELARDINELLI, L ;
LINDEN, J ;
BERNE, RM .
PROGRESS IN CARDIOVASCULAR DISEASES, 1989, 32 (01) :73-97
[5]   ROLE OF GUANINE NUCLEOTIDE-BINDING PROTEIN IN THE REGULATION BY ADENOSINE OF CARDIAC POTASSIUM CONDUCTANCE AND FORCE OF CONTRACTION - EVALUATION WITH PERTUSSIS TOXIN [J].
BOHM, M ;
BRUCKNER, R ;
NEUMANN, J ;
SCHMITZ, W ;
SCHOLZ, H ;
STARBATTY, J .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 332 (04) :403-405
[6]   FUNCTIONAL EVIDENCE FOR THE EXISTENCE OF ADENOSINE RECEPTORS IN THE HUMAN-HEART [J].
BOHM, M ;
MEYER, W ;
MUGGE, A ;
SCHMITZ, W ;
SCHOLZ, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 116 (03) :323-326
[7]  
BOHM M, 1988, BRIT J PHARMACOL, V93, P729
[8]  
BOHM M, 1984, J PHARMACOL EXP THER, V230, P483
[9]   CHARACTERIZATION OF A1 ADENOSINE RECEPTORS IN ATRIAL AND VENTRICULAR MYOCARDIUM FROM DISEASED HUMAN HEARTS [J].
BOHM, M ;
PIESKE, B ;
UNGERER, M ;
ERDMANN, E .
CIRCULATION RESEARCH, 1989, 65 (05) :1201-1211
[10]  
BOHM M, 1989, N-S ARCH PHARMACOL, V339, P152